Magistro Giuseppe, Tuong-Linh Le Doan, Westhofen Thilo, Buchner Alexander, Schlenker Boris, Becker Armin, Stief Christian G
Department of Urology, Ludwig-Maximilians-University of Munich, Munich, Germany.
Cent European J Urol. 2021;74(3):341-347. doi: 10.5173/ceju.2021.3.150. Epub 2021 Sep 9.
The aim of this article was to evaluate the prevalence and predictors of symptomatic lymphocele after open retropubic radical prostatectomy (RRP) and robot-assisted radical prostatectomy (RARP).
A total of 472 patients undergoing RRP (n = 241) or RARP (n = 231) were retrospectively analyzed with a 2-year follow-up for age, body mass index (BMI), total serum prostate-specific antigen (PSA), lymphocele formation and histopathological features. Univariate and multivariate logistic regression models were used to identify independent predictors of symptomatic lymphocele.
Patients undergoing RRP developed significantly less overall lymphoceles than after RARP (8.2% vs 16.7%; p = 0.049), but no difference was determined for symptomatic events requiring intervention (7.4% vs 11.7%, p = 0.315). Although more pelvic lymph node dissections (PLND) were performed during RARP (70.1% vs 50.6%; p <0.001), significantly more cases with lymphatic invasion were observed after RRP (18% vs 6.2%, p = 0.002). The median lymph node yield during RRP and RARP were 11 and 10, respectively (p = 0.381). In multivariate logistic regression, we identified the number of dissected lymph nodes (n = 11) (OR 1.1; 95% Cl 1.055 - 1.147; p = 0.001), the Gleason score ≥ 8 (OR 4.7; 95% Cl 2.365 - 9.363; p = 0.001) and the total PSA ≥10 ng/ml (OR 1.05; 95% Cl 1.02 - 1.074; p = 0.001) as independent predictors for the development of symptomatic lymphocele.
Next to an extended lymph node yield, high-grade disease was associated with a higher risk to develop symptomatic lymphocele irrespective of the technical approach. The identification of risk factors might prove valuable in clinical practice when assessing and counselling patients considering surgical treatment of prostate cancer.
本文旨在评估开放性耻骨后根治性前列腺切除术(RRP)和机器人辅助根治性前列腺切除术(RARP)后症状性淋巴囊肿的发生率及预测因素。
对472例行RRP(n = 241)或RARP(n = 231)的患者进行回顾性分析,随访2年,记录年龄、体重指数(BMI)、血清总前列腺特异性抗原(PSA)、淋巴囊肿形成情况及组织病理学特征。采用单因素和多因素逻辑回归模型确定症状性淋巴囊肿的独立预测因素。
RRP患者总体淋巴囊肿发生率显著低于RARP患者(8.2%对16.7%;p = 0.049),但在需要干预的症状性事件方面无差异(7.4%对11.7%,p = 0.315)。尽管RARP术中进行盆腔淋巴结清扫(PLND)的比例更高(70.1%对50.6%;p <0.001),但RRP术后观察到淋巴浸润的病例明显更多(18%对6.2%,p = 0.002)。RRP和RARP术中淋巴结清扫的中位数分别为11个和10个(p = 0.381)。在多因素逻辑回归中,我们确定清扫淋巴结数量(n = 11)(OR 1.1;95% CI 1.055 - 1.147;p = 0.001)、Gleason评分≥8(OR 4.7;95% CI 2.365 - 9.363;p = 0.001)以及总PSA≥10 ng/ml(OR 1.05;95% CI 1.02 - 1.074;p = 0.001)为症状性淋巴囊肿发生的独立预测因素。
除了淋巴结清扫范围扩大外,无论采用何种技术方法,高级别疾病发生症状性淋巴囊肿的风险更高。在评估和咨询考虑前列腺癌手术治疗的患者时,识别危险因素在临床实践中可能具有重要价值。